
Fortune Formulations & Bulk Drugs Private Limited
Founded in 2016 and headquartered in Telangana, India.
Founded in 2016 and headquartered in Telangana, India.
Hyderabad, Telangana, India
+91-XXXXXXXXXX
U74999TG2016PTC111949
111949
Private Limited Indian Non-Government Company
14 Sep 2016
-
-
Unlisted
Roc Hyderabad
Name | Designation | Appointment Date | Status |
---|---|---|---|
Rajiv Challa ![]() | Director | 14-Sep-2016 | Current |
Malathi Challa ![]() | Director | 14-Sep-2016 | Current |
Enhance accessibility to Fortune Formulations & Bulk Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Fortune Formulations & Bulk Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Rajiv Challa and Malathi Challa are mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Fortune Formulations & Bulk Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Fortune Formulations & Bulk Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fortune Formulations & Bulk Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Rajiv Reddy Challa was appointed as a Director was appointed as a Director on 14 Sep 2016 & has been associated with this company since 8 years 6 months .
Malathi Challa was appointed as a Director was appointed as a Director on 14 Sep 2016 & has been associated with this company since 8 years 6 months .
Fortune Formulations & Bulk Drugs Private Limited was registered on 14 Sep 2016 with Roc Hyderabad & aged 8 years 6 months as per MCA records.
Fortune Formulations & Bulk Drugs Private Limited was incorporated on 14 Sep 2016.
The authorized share capital of Fortune Formulations & Bulk Drugs Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Currently 2 directors are associated with Fortune Formulations & Bulk Drugs Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Fortune Formulations & Bulk Drugs Private Limited is D. No.2-14-49/2/178/Eastern 2Nd Floor North Block Street No.14 Surya Nagar Colony, Uppal India, Hyderabad, Telangana, 500039.
The corporate identification number (CIN) of Fortune Formulations & Bulk Drugs Private Limited is U74999TG2016PTC111949 and the company number is 111949 as per Ministry of Corporate Affairs (MCA).